(Q44569037)

English

Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide: variability in response and involvement of arachidonic acid

scientific article published in September 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide: variability in response and involvement of arachidonic acid (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

0 references

0 references

author name string

Christopher J Fowler

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Kent-Olov Jonsson

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Anna Andersson

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Juha Juntunen

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Tomi Järvinen

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Séverine Vandevoorde

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Didier M Lambert

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Jeffrey C Jerman

8

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Darren Smart

9

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

0 references

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Biochemical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

66

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

757-767

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

The evidence for the existence of cannabinoid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Targeting the endocannabinoid system in cancer therapy: a call for further research

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Endocannabinoids in the immune system and cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Delta9-tetrahydrocannabinol stimulates glucose utilization in C6 glioma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Specific vanilloid responses in C6 rat glioma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

(R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Cannabinoid activation of recombinant and endogenous vanilloid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

AM404 and VDM 11 non-specifically inhibit C6 glioma cell proliferation at concentrations used to block the cellular accumulation of the endocannabinoid anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Stimulation of dichlorofluorescin oxidation by capsaicin and analogues in RAW 264 monocyte/macrophages: lack of involvement of the vanilloid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Chemical stability of 2-arachidonylglycerol under biological conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Anandamide prodrugs. 1. Water-soluble phosphate esters of arachidonylethanolamide and R-methanandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Characterisation using FLIPR of human vanilloid VR1 receptor pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Pharmacological differences between the human and rat vanilloid receptor 1 (VR1)

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Trifluoromethyl ketones and methyl fluorophosphonates as inhibitors of group IV and VI phospholipases A2: structure-function studies with vesicle, micelle, and membrane assays1This paper is dedicated to the memory of Prof. H.M. Verheij.1

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Altered genetic response to beta-adrenergic receptor activation in late passage C6 glioma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

The endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Receptor mediation in cannabinoid stimulated arachidonic acid mobilization and anandamide synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Brain monoglyceride lipase participating in endocannabinoid inactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Clearance and metabolism of arachidonic acid by C6 glioma cells and astrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

A continuous fluorescence-based assay for the human high-molecular-weight cytosolic phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Molecular basis for species-specific sensitivity to "hot" chili peppers

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide--targets for drug development?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Proteins regulating the biosynthesis and inactivation of neuromodulatory fatty acid amides

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Evidence against the presence of an anandamide transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Characterization of the anandamide induced depolarization of guinea-pig isolated vagus nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

15-Lipoxygenase metabolism of 2-arachidonylglycerol. Generation of a peroxisome proliferator-activated receptor alpha agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900392-7

7 January 2021

Identifiers

10.1016/S0006-2952(03)00392-7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44569037&oldid=2028419797"